Drug selection for simultaneous treatment of tuberculosis combined with hepatitis C virus infection / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 113-116, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-935920
ABSTRACT
Clinically, patients with tuberculosis (TB) combined with hepatitis C virus (HCV) infection often require simultaneous treatment. Consequently, when anti-HCV and TB drugs are used in combination drug-drug interactions (DDIs), anti-TB drug-induced hepatotoxicity, and liver disease states need to be considered. This paper focuses on discussing the metabolic mechanisms of commonly used anti-TB and HCV drugs and the selection options of combined drugs, so as to provide rational drug use for TB patients combined with HCV infection.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tuberculosis
/
Pharmaceutical Preparations
/
Hepatitis C
/
Hepacivirus
/
Chemical and Drug Induced Liver Injury
/
Coinfection
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS